MP
About
Mark Pruzanski is based out of United States, and is the Chairman of the Board of Inventiva Pharma and Chief Executive Officer of Alentis Therapeutics. Mark previously worked at EGenesis as Board of Director. Mark Pruzanski attended McMaster University Medical School.
Position in the VCSift Database
- • 1,305 investors hold the Chief Executive Officer role in VCSift. Mark Pruzanski is one of them.
- • 2,799 investors are based in United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- US
Contact Information
linkedin.com/in/••••••••
Find more investors like Mark
Search Investors